Literature DB >> 26976617

Overview on acute-on-chronic liver failure.

Jing Zhang1,2, Shan Gao3,2, Zhongping Duan4,5, Ke-Qin Hu6.   

Abstract

Liver failure (LF) is defined as severe dysfunction in hepatic synthesis, detoxification, and metabolism induced by various etiologies. Clinical presentation of LF typically includes severe jaundice, coagulation disorder, hepatic encephalopathy, and ascites. LF can be classified into acute LF, acute-on-chronic LF (ACLF), and chronic LF. ACLF has been demonstrated as a distinct syndrome with unique clinical presentation and outcomes. The severity, curability, and reversibility of ACLF have attracted considerable attention. Remarkable developments in ACLF-related conception, diagnostic criteria, pathogenesis, and therapy have been achieved. However, this disease, especially its diagnostic criteria, remains controversial. In this paper, we systemically reviewed the current understanding of ACLF from its definition, etiology, pathophysiology, pathology, and clinical presentation to management by thoroughly comparing important findings between east and west countries, as well as those from other regions. We also discussed the controversies, challenges, and needs for future studies to promote the standardization and optimization of the diagnosis and treatment for ACLF.

Entities:  

Keywords:  acute-on-chronic liver failure; chronic liver failure; diagnosis; liver failure; prognosis; treatment

Mesh:

Year:  2016        PMID: 26976617     DOI: 10.1007/s11684-016-0439-x

Source DB:  PubMed          Journal:  Front Med        ISSN: 2095-0217            Impact factor:   4.592


  100 in total

1.  Clinical Course of acute-on-chronic liver failure syndrome and effects on prognosis.

Authors:  Thierry Gustot; Javier Fernandez; Elisabet Garcia; Filippo Morando; Paolo Caraceni; Carlo Alessandria; Wim Laleman; Jonel Trebicka; Laure Elkrief; Corinna Hopf; Pablo Solís-Munoz; Faouzi Saliba; Stefan Zeuzem; Augustin Albillos; Daniel Benten; José Luis Montero-Alvarez; Maria Teresa Chivas; Mar Concepción; Juan Córdoba; Aiden McCormick; Rudolf Stauber; Wolfgang Vogel; Andrea de Gottardi; Tania M Welzel; Marco Domenicali; Alessandro Risso; Julia Wendon; Carme Deulofeu; Paolo Angeli; François Durand; Marco Pavesi; Alexander Gerbes; Rajiv Jalan; Richard Moreau; Pere Ginés; Mauro Bernardi; Vicente Arroyo
Journal:  Hepatology       Date:  2015-05-29       Impact factor: 17.425

2.  Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial.

Authors:  Rafael Bañares; Frederik Nevens; Fin Stolze Larsen; Rajiv Jalan; Agustín Albillos; Matthias Dollinger; Faouzi Saliba; Tilman Sauerbruch; Sebastian Klammt; Johann Ockenga; Albert Pares; Julia Wendon; Tanja Brünnler; Ludwig Kramer; Philippe Mathurin; Manuel de la Mata; Antonio Gasbarrini; Beat Müllhaupt; Alexander Wilmer; Wim Laleman; Martin Eefsen; Sambit Sen; Alexander Zipprich; Teresa Tenorio; Marco Pavesi; Hartmut H-J Schmidt; Steffen Mitzner; Roger Williams; Vicente Arroyo
Journal:  Hepatology       Date:  2013-02-15       Impact factor: 17.425

3.  Correcting thrombocytopenia in patients with liver diseases: a difficult hurdle.

Authors:  Chun-Tao Wai
Journal:  J Gastroenterol Hepatol       Date:  2013-02       Impact factor: 4.029

4.  Acute kidney injury in decompensated cirrhosis.

Authors:  Cynthia D Tsien; Rania Rabie; Florence Wong
Journal:  Gut       Date:  2012-05-25       Impact factor: 23.059

5.  Acute-on-chronic liver failure precipitated by hepatic injury is distinct from that precipitated by extrahepatic insults.

Authors:  Yu Shi; Ying Yang; Yaoren Hu; Wei Wu; Qiao Yang; Min Zheng; Shun Zhang; Zhaojun Xu; Yihua Wu; Huadong Yan; Zhi Chen
Journal:  Hepatology       Date:  2015-04-25       Impact factor: 17.425

6.  Nucleoside analogue can improve the long-term prognosis of patients with hepatitis B virus infection-associated acute on chronic liver failure.

Authors:  Yao-Li Cui; Fang Yan; Yue-Bin Wang; Xue-Qin Song; Li Liu; Xue-Zhong Lei; Ming-Hua Zheng; Hong Tang; Ping Feng
Journal:  Dig Dis Sci       Date:  2010-05-29       Impact factor: 3.199

7.  Hepatic and systemic hemodynamic derangements predict early mortality and recovery in patients with acute-on-chronic liver failure.

Authors:  Hitendra Garg; Ashish Kumar; Vishal Garg; Manoj Kumar; Ramesh Kumar; Barjesh Chander Sharma; Shiv Kumar Sarin
Journal:  J Gastroenterol Hepatol       Date:  2013-08       Impact factor: 4.029

8.  Liver transplantation in acute-on-chronic liver failure patients with high model for end-stage liver disease (MELD) scores: a single center experience of 100 consecutive cases.

Authors:  Bin-Wei Duan; Shi-Chun Lu; Meng-Long Wang; Jin-Ning Liu; Ping Chi; Wei Lai; Ju-Shan Wu; Qing-Liang Guo; Dong-Dong Lin; Yuan Liu; Dao-Bing Zeng; Chuan-Yun Li; Qing-Hua Meng; Hui-Guo Ding; Xin-Yue Chen; Hui-Yu Liao; Lie-Qing Ma; Yu Chen; Jing Zhang; Hai-Ping Xiang; Zhong-Ping Duan; Ning Li
Journal:  J Surg Res       Date:  2013-03-26       Impact factor: 2.192

9.  CLIF-SOFA scoring system accurately predicts short-term mortality in acutely decompensated patients with alcoholic cirrhosis: a retrospective analysis.

Authors:  Minjong Lee; Jeong-Hoon Lee; Sohee Oh; Yoonhyuk Jang; Wonik Lee; Hyung Joo Lee; Jeong-Ju Yoo; Won-Mook Choi; Young Youn Cho; Yuri Cho; Dong Hyeon Lee; Yun Bin Lee; Su Jong Yu; Nam-Joon Yi; Kwang-Woong Lee; Yoon Jun Kim; Jung-Hwan Yoon; Kyung-Suk Suh; Hyo-Suk Lee
Journal:  Liver Int       Date:  2014-10-01       Impact factor: 5.828

10.  Meta-analysis of the short-term effects of lamivudine treatment for severe chronic hepatitis B.

Authors:  Lin Zhang; Chun-Qiu Hao; Jiang-Fu Liu; Meng Wang
Journal:  Virol J       Date:  2013-04-29       Impact factor: 4.099

View more
  2 in total

1.  Aloin Inhibits Müller Cells Swelling in a Rat Model of Thioacetamide-Induced Hepatic Retinopathy.

Authors:  Eunsoo Jung; Junghyun Kim
Journal:  Molecules       Date:  2018-10-29       Impact factor: 4.411

2.  HBV-related acute-on-chronic liver failure with underlying chronic hepatitis has superior survival compared to cirrhosis.

Authors:  Xiaohui Liu; Jing Zhang; Xinhuan Wei; Zhongping Duan; Hongqun Liu; Yu Chen; Yali Liu; Samuel S Lee
Journal:  Eur J Gastroenterol Hepatol       Date:  2021-12-01       Impact factor: 2.586

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.